Nephron To Receive $7.9M To End Trade Secrets Case

Law360 (May 6, 2021, 6:21 PM EDT) -- U.S. Compounding Inc. and its parent Adamis Pharmaceuticals Corp. have agreed to pay $7.9 million as part of a deal to end a lawsuit by Nephron Pharmaceuticals Corp. claiming they stole its trade secrets through a former employee.

In a motion filed late Wednesday, the companies and former Nephron employee Jennifer Shelly Hulsey asked U.S. District Judge Gregory A. Presnell to sign off on a permanent injunction and stipulated final judgment. The proposed order requires the defendants to destroy and not use any of Nephron's confidential information in their possession, but it does not require U.S. Compounding to discontinue business with...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!